DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY

用于治疗的图像增强放射性药物的开发

• 批准号: 7953909
• 负责人: ROBERT H MACH
• 金额: $ 0.17万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-02-01 至 2010-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7953909
• 关键词: Arts; Computer Retrieval of Information on Scientific Projects Database; Cyclotrons; Development; Equipment; Faculty; Funding; Grant; Image; Image Enhancement; Image Enhancement Agent; Institutes; Institution; Investigation; Laboratories; Linear Accelerator Radiotherapy Systems; Magnetic Resonance Imaging; Mass Spectrum Analysis; Photons; Positron; Postdoctoral Fellow; Production; Quality Control; Radioisotopes; Radiology Specialty; Radiopharmaceuticals; Research; Research Personnel; Resources; Science; Source; Targeted Radiotherapy; United States National Institutes of Health; Universities; Washington; biomedical resource; graduate student; medical schools; member; single photon emission computed tomography

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This laboratory carries out research on the development of image enhancement agents and radiopharmaceuticals for therapy. The laboratory is in the Division of Radiological Sciences in the Mallinckrodt Institute, Department of Radiology, Washington University Medical School and has eight faculty members, five post doctoral Research Associates, two graduate students and approximately 16 support staff. The laboratory operates two cyclotrons and a linear accelerator for radionuclide production and maintains state-of-the-art equipment for synthesis, separation and quality control of agents for imaging and therapy. Research is carried out in development of both inorganic and organic compounds for positron emission tomographic (PET), single photon emitted tomographic (SPECT) and magnetic resonance (MR) imaging applications. Radiopharmaceuticals are also developed for the investigation of targeted radiotherapy.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此，可以在其他清晰的条目中表示。列出的机构是 对于中心，这不一定是调查员的机构。 该实验室对图像增强剂和放射性药物治疗的发展进行了研究。该实验室位于华盛顿大学医学院放射学系Mallinckrodt研究所的放射科学系，有8位教职员工，五名博士后研究员，两名研究生和大约16名支持人员。该实验室运营两个环体基质和一个线性加速器，用于放射性核素生产，并维护最先进的设备，用于用于成像和治疗的剂的合成，分离和质量控制。在开发正电子发射断层扫描（PET），单光子发射层析成像（SPECT）和磁共振（MR）成像应用的无机化合物和有机化合物方面进行了研究。还开发了用于研究靶向放射疗法的放射药物。